The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
New perspectives on the role of SERCA2's Ca2+ affinity in cardiac function
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“the idea emerges that PLN does not function as a simple on/off switch for Ca 2 + translocation; rather, its conformational equilibrium exerts a gradual control ( ' physiological rheostat ' ) on SERCA activity that determines SERCA ' s physiological window of function (38).”
From Allosteric regulation of SERCA by phosphorylation-mediated conformational shift of phospholamban (2013) · cites this paper as [38]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sensitivity of CaM Kinase II to the Frequency of Ca 2+ Oscillations
De Koninck, P., & Schulman, H. (1998) · Science · doi:10.1126/science.279.5348.227 · Cited by 1,269
Phospholamban: a crucial regulator of cardiac contractility
MacLennan, D. H., & Kranias, E. G. (2003) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1151 · Cited by 1,088
Involvement of a calcineurin/ inhibitor-1 phosphatase cascade in hippocampal long-term depression
Mulkey, R. M., Endo, S., Shenolikar, S., & Malenka, R. C. (1994) · Nature · doi:10.1038/369486a0 · Cited by 1,083 · cited 1×
“further occur upon calcineurin activation [88], a Ca-calmodulin-dependent phosphatase which plays a pivotal role in the hypertrophic response [89].”
BackgroundMutations in ATP2A2, encoding a Ca2+ pump, cause Darier disease
Sakuntabhai, A., Ruiz-Perez, V., Carter, S., Jacobsen, N., Burge, S., Monk, S., Smith, M., Munro, C. S., O'Donovan, M., Craddock, N., et al. (1999) · Nature Genetics · doi:10.1038/6784 · Cited by 740
Relaxation in rabbit and rat cardiac cells: species-dependent differences in cellular mechanisms
Bassani, J. W., Bassani, R. A., & Bers, D. M. (1994) · The Journal of Physiology · doi:10.1113/jphysiol.1994.sp020130 · Cited by 662
Alterations of Sarcoplasmic Reticulum Proteins in Failing Human Dilated Cardiomyopathy
Meyer, M., Schillinger, W., Pieske, B., Holubarsch, C., Heilmann, C., Posival, H., Kuwajima, G., Mikoshiba, K., Just, H., & Hasenfuss, G. (1995) · Circulation · doi:10.1161/01.cir.92.4.778 · Cited by 535
Schwinger, R. H. G., Böhm, M., Schmidt, U., Karczewski, P., Bavendiek, U., Flesch, M., Krause, E.-G., & Erdmann, E. (1995) · Circulation · doi:10.1161/01.cir.92.11.3220 · Cited by 395
del Monte, F., Williams, E., Lebeche, D., Schmidt, U., Rosenzweig, A., Gwathmey, J. K., Lewandowski, E. D., & Hajjar, R. J. (2001) · Circulation · doi:10.1161/hc3601.095574 · Cited by 382
The enhanced contractility of the phospholamban-deficient mouse heart persists with aging
Slack, J. P., Grupp, I. L., Dash, R., Holder, D., Schmidt, A., Gerst, M. J., Tamura, T., Tilgmann, C., James, P. F., Johnson, R., et al. (2001) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.2001.1370 · Cited by 64
Research works printed but not linked: 125
- Schaub, 2006, Integration of calcium with the signaling network in cardiac myocytes, J. Mol. Cell. Cardiol., 41, 183, 10.1016/j.yjmcc.2006.04.005 · DOI
- Ringer, 1883, A further contribution regarding the influence of the different constituents of the blood on the contraction of the heart, J. Physiol., 4, 29, 10.1113/jphysiol.1883.sp000120 · DOI · Paper page
- Bers, 2002, Cardiac excitation–contraction coupling, Nature, 415, 198, 10.1038/415198a · DOI · Paper page
- Li, 1998, Cardiac myocyte calcium transport in phospholamban knockout mouse: relaxation and endogenous CaMKII effects, Am. J. Physiol., 274, H1335
- Periasamy, 2001, SERCA pump level is a critical determinant of Ca2+ homeostasis and cardiac contractility, J. Mol. Cell. Cardiol., 33, 1053, 10.1006/jmcc.2001.1366 · DOI · Paper page
- Campbell, 1991, Nucleotide sequences of avian cardiac and brain SR/ER Ca2+-ATPases and functional comparisons with fast twitch Ca2+-ATPase. Calcium affinities and inhibitor effects, J. Biol. Chem., 266, 16050, 10.1016/S0021-9258(18)98514-5 · DOI
- Lytton, 1992, Functional comparisons between isoforms of the sarcoplasmic or endoplasmic reticulum family of calcium pumps, J. Biol. Chem., 267, 14483, 10.1016/S0021-9258(19)49738-X · DOI · Paper page
- Verboomen, 1992, Functional difference between SERCA2a and SERCA2b Ca2+ pumps and their modulation by phospholamban, Biochem. J., 286, 591, 10.1042/bj2860591 · DOI
- Verboomen, 1994, The functional importance of the extreme C-terminal tail in the gene 2 organellar Ca2+-transport ATPase (SERCA2a/b), Biochem. J., 303, 979, 10.1042/bj3030979 · doi:10.1042/bj3030979
- Dode, 2003, Dissection of the functional differences between sarco(endo)plasmic reticulum Ca2+-ATPase (SERCA) 1 and 2 isoforms and characterization of Darier disease (SERCA2) mutants by steady-state and transient kinetic analyses, J. Biol. Chem., 278, 47877, 10.1074/jbc.M306784200 · DOI
- Ver Heyen, 2001, Replacement of the muscle-specific sarcoplasmic reticulum Ca2+-ATPase isoform SERCA2a by the nonmuscle SERCA2b homologue causes mild concentric hypertrophy and impairs contraction–relaxation of the heart, Circ. Res., 89, 838, 10.1161/hh2101.098466 · DOI
- Vangheluwe, 2006, A SERCA2 pump with an increased Ca2+ affinity can lead to severe cardiac hypertrophy, stress intolerance and reduced life span, J. Mol. Cell. Cardiol., 41, 308, 10.1016/j.yjmcc.2006.05.014 · DOI
- Zarain-Herzberg, 1990, Characterization of rabbit cardiac sarco(endo)plasmic reticulum Ca2+-ATPase gene, J. Biol. Chem., 265, 4670, 10.1016/S0021-9258(19)39615-2 · DOI · Paper page
- Baba-Aissa, 1996, Distribution of the organellar Ca2+ transport ATPase SERCA2 isoforms in the cat brain, Brain Res., 743, 141, 10.1016/S0006-8993(96)01037-2 · doi:10.1016/s0006-8993(96)01037-2
- Vangheluwe, 2003, Ca2+ transport ATPase isoforms SERCA2a and SERCA2b are targeted to the same sites in the murine heart, Cell Calcium, 34, 457, 10.1016/S0143-4160(03)00126-X · doi:10.1016/s0143-4160(03)00126-x
- Lytton, 1989, Molecular cloning of the mammalian smooth muscle sarco(endo)plasmic reticulum Ca2+-ATPase, J. Biol. Chem., 264, 7059, 10.1016/S0021-9258(18)83540-2 · DOI
- Van den Bosch, 1994, Regulation of splicing is responsible for the expression of the muscle-specific 2a isoform of the sarco/endoplasmic-reticulum Ca2+-ATPase, Biochem. J., 302, 559, 10.1042/bj3020559 · DOI
- Escalante, 1993, Similar alternative splicing events generate two sarcoplasmic or endoplasmic reticulum Ca2+-ATPase isoforms in the crustacean Artemia franciscana and in vertebrates, J. Biol. Chem., 268, 14090, 10.1016/S0021-9258(19)85212-2 · doi:10.1016/s0021-9258(19)85212-2
- Zwaal, 2001, The sarco-endoplasmic reticulum Ca2+ ATPase is required for development and muscle function in Caenorhabditis elegans, J. Biol. Chem., 276, 43557, 10.1074/jbc.M104693200 · DOI
- Dode, 1996, cDNA cloning, expression and chromosomal localization of the human sarco/endoplasmic reticulum Ca2+-ATPase 3 gene, Biochem. J., 318, 689, 10.1042/bj3180689 · DOI
- Koss, 1995, Differential phospholamban gene expression in murine cardiac compartments. Molecular and physiological analyses, Circ. Res., 77, 342, 10.1161/01.RES.77.2.342 · DOI
- Kimura, 1998, Phospholamban domain Ib mutations influence functional interactions with the Ca2+-ATPase isoform of cardiac sarcoplasmic reticulum, J. Biol. Chem., 273, 14238, 10.1074/jbc.273.23.14238 · DOI · Paper page
- Cantilina, 1993, Comparative studies of cardiac and skeletal sarcoplasmic reticulum ATPases. Effect of a phospholamban antibody on enzyme activation by Ca2+, J. Biol. Chem., 268, 17018, 10.1016/S0021-9258(19)85295-X · DOI · Paper page
- Luo, 1994, Targeted ablation of the phospholamban gene is associated with markedly enhanced myocardial contractility and loss of beta-agonist stimulation, Circ. Res., 75, 401, 10.1161/01.RES.75.3.401 · DOI · Paper page
- Reddy, 2003, Defining the molecular components of calcium transport regulation in a reconstituted membrane system, Biochemistry, 42, 4585, 10.1021/bi026995a · DOI · Paper page
- Trieber, 2005, The effects of mutation on the regulatory properties of phospholamban in co-reconstituted membranes, Biochemistry, 44, 3289, 10.1021/bi047878d · DOI
- James, 1989, Nature and site of phospholamban regulation of the Ca2+ pump of sarcoplasmic reticulum, Nature, 342, 90, 10.1038/342090a0 · DOI · Paper page
- Simmerman, 1986, Sequence analysis of phospholamban. Identification of phosphorylation sites and two major structural domains, J. Biol. Chem., 261, 13333, 10.1016/S0021-9258(18)69309-3 · DOI · Paper page
- Wegener, 1989, Phospholamban phosphorylation in intact ventricles. Phosphorylation of serine 16 and threonine 17 in response to beta-adrenergic stimulation, J. Biol. Chem., 264, 11468, 10.1016/S0021-9258(18)60487-9 · DOI · Paper page
- MacDougall, 1991, Identification of the major protein phosphatases in mammalian cardiac muscle which dephosphorylate phospholamban, Eur. J. Biochem., 196, 725, 10.1111/j.1432-1033.1991.tb15871.x · DOI · Paper page
- Luo, 1996, Phospholamban gene dosage effects in the mammalian heart, Circ. Res., 78, 839, 10.1161/01.RES.78.5.839 · DOI
- Desai, 1999, Phospholamban deficiency does not compromise exercise capacity, Am. J. Physiol., 276, H1172
- Kadambi, 1996, Cardiac-specific overexpression of phospholamban alters calcium kinetics and resultant cardiomyocyte mechanics in transgenic mice, J. Clin. Invest., 97, 533, 10.1172/JCI118446 · DOI · Paper page
- Dash, 2001, Interactions between phospholamban and beta-adrenergic drive may lead to cardiomyopathy and early mortality, Circulation, 103, 889, 10.1161/01.CIR.103.6.889 · DOI
- Zvaritch, 2000, The transgenic expression of highly inhibitory monomeric forms of phospholamban in mouse heart impairs cardiac contractility, J. Biol. Chem., 275, 14985, 10.1074/jbc.275.20.14985 · DOI
- Haghighi, 2001, Superinhibition of sarcoplasmic reticulum function by phospholamban induces cardiac contractile failure, J. Biol. Chem., 276, 24145, 10.1074/jbc.M102403200 · DOI · Paper page
- Schmidt, 2002, Structural and functional implications of the phospholamban hinge domain: impaired SR Ca2+ uptake as a primary cause of heart failure, Cardiovasc. Res., 56, 248, 10.1016/S0008-6363(02)00541-2 · DOI
- Mattiazzi, 2005, Role of phospholamban phosphorylation on Thr17 in cardiac physiological and pathological conditions, Cardiovasc. Res., 68, 366, 10.1016/j.cardiores.2005.08.010 · DOI · Paper page
- Chu, 2000, A single site (Ser16) phosphorylation in phospholamban is sufficient in mediating its maximal cardiac responses to beta-agonists, J. Biol. Chem., 275, 38938, 10.1074/jbc.M004079200 · DOI · Paper page
- Vittone, 1990, cAMP and calcium-dependent mechanisms of phospholamban phosphorylation in intact hearts, Am. J. Physiol., 258, H318
- Mundina-Weilenmann, 1996, Immunodetection of phosphorylation sites gives new insights into the mechanisms underlying phospholamban phosphorylation in the intact heart, J. Biol. Chem., 271, 33561, 10.1074/jbc.271.52.33561 · DOI
- Said, 2002, The relative relevance of phosphorylation of the Thr17 residue of phospholamban is different at different levels of beta-adrenergic stimulation, Pflugers Arch., 444, 801, 10.1007/s00424-002-0885-y · doi:10.1007/s00424-002-0885-y
- Hagemann, 2000, Frequency-encoding Thr17 phospholamban phosphorylation is independent of Ser16 phosphorylation in cardiac myocytes, J. Biol. Chem., 275, 22532, 10.1074/jbc.C000253200 · DOI
- Zhao, 2004, Threonine-17 phosphorylation of phospholamban: a key determinant of frequency-dependent increase of cardiac contractility, J. Mol. Cell. Cardiol., 37, 607, 10.1016/j.yjmcc.2004.05.013 · DOI
- Bassani, 1995, CaMKII is responsible for activity-dependent acceleration of relaxation in rat ventricular myocytes, Am. J. Physiol., 268, H703
- DeSantiago, 2002, Frequency-dependent acceleration of relaxation in the heart depends on CaMKII, but not phospholamban, J. Mol. Cell. Cardiol., 34, 975, 10.1006/jmcc.2002.2034 · DOI · Paper page
- Valverde, 2005, Frequency-dependent acceleration of relaxation in mammalian heart: a property not relying on phospholamban and SERCA2a phosphorylation, J. Physiol., 562, 801, 10.1113/jphysiol.2004.075432 · DOI
- Odermatt, 1997, Characterization of the gene encoding human sarcolipin (SLN), a proteolipid associated with SERCA1: absence of structural mutations in five patients with Brody disease, Genomics, 45, 541, 10.1006/geno.1997.4967 · DOI · Paper page
- Asahi, 2002, Sarcolipin inhibits polymerization of phospholamban to induce superinhibition of sarco(endo)plasmic reticulum Ca2+-ATPases (SERCAs), J. Biol. Chem., 277, 26725, 10.1074/jbc.C200269200 · DOI
- Asahi, 2004, Cardiac-specific overexpression of sarcolipin inhibits sarco(endo)plasmic reticulum Ca2+ ATPase (SERCA2a) activity and impairs cardiac function in mice, Proc. Natl. Acad. Sci. U. S. A., 101, 9199, 10.1073/pnas.0402596101 · DOI
- Gramolini, 2004, Sarcolipin retention in the endoplasmic reticulum depends on its C-terminal RSYQY sequence and its interaction with sarco(endo)plasmic Ca2+-ATPases, Proc. Natl. Acad. Sci. U. S. A., 101, 16807, 10.1073/pnas.0407815101 · DOI
- Asahi, 2003, Sarcolipin regulates sarco(endo)plasmic reticulum Ca2+-ATPase (SERCA) by binding to transmembrane helices alone or in association with phospholamban, Proc. Natl. Acad. Sci. U. S. A., 100, 5040, 10.1073/pnas.0330962100 · DOI · Paper page
- Hellstern, 2001, Sarcolipin, the shorter homologue of phospholamban, forms oligomeric structures in detergent micelles and in liposomes, J. Biol. Chem., 276, 30845, 10.1074/jbc.M102495200 · DOI
- Babu, 2005, Overexpression of sarcolipin decreases myocyte contractility and calcium transient, Cardiovasc. Res., 65, 177, 10.1016/j.cardiores.2004.08.012 · DOI
- Gayan-Ramirez, 2000, Corticosteroids decrease mRNA levels of SERCA pumps, whereas they increase sarcolipin mRNA in the rat diaphragm, J. Physiol., 524, 387, 10.1111/j.1469-7793.2000.t01-2-00387.x · DOI
- Minamisawa, 2003, Atrial chamber-specific expression of sarcolipin is regulated during development and hypertrophic remodeling, J. Biol. Chem., 278, 9570, 10.1074/jbc.M213132200 · DOI
- Vangheluwe, 2005, Sarcolipin and phospholamban mRNA and protein expression in cardiac and skeletal muscle of different species, Biochem. J., 389, 151, 10.1042/BJ20050068 · DOI
- Minajeva, 1997, Sarcoplasmic reticulum function in determining atrioventricular contractile differences in rat heart, Am. J. Physiol., 273, H2498
- Babu, 2006, Targeted overexpression of sarcolipin in the mouse heart decreases sarcoplasmic reticulum calcium transport and cardiac contractility, J. Biol. Chem., 281, 3972, 10.1074/jbc.M508998200 · DOI
- Gramolini, 2006, Cardiac-specific overexpression of sarcolipin in phospholamban null mice impairs myocyte function that is restored by phosphorylation, Proc. Natl. Acad. Sci. U. S. A., 103, 2446, 10.1073/pnas.0510883103 · DOI
- Freestone, 2000, Differential lusitropic responsiveness to beta-adrenergic stimulation in rat atrial and ventricular cardiac myocytes, Pflugers Arch., 441, 78, 10.1007/s004240000397 · doi:10.1007/s004240000397
- Kaasik, 2001, Decreased expression of phospholamban is not associated with lower beta-adrenergic activation in rat atria, Mol. Cell. Biochem., 223, 109, 10.1023/A:1017945810355 · doi:10.1023/a:1017945810355
- Odermatt, 1998, Sarcolipin regulates the activity of SERCA1, the fast-twitch skeletal muscle sarcoplasmic reticulum Ca2+-ATPase, J. Biol. Chem., 273, 12360, 10.1074/jbc.273.20.12360 · DOI · Paper page
- Morgan, 1990, Abnormal intracellular calcium handling, a major cause of systolic and diastolic dysfunction in ventricular myocardium from patients with heart failure, Circulation, 81, III21
- Beuckelmann, 1992, Intracellular calcium handling in isolated ventricular myocytes from patients with terminal heart failure, Circulation, 85, 1046, 10.1161/01.CIR.85.3.1046 · DOI · Paper page
- Hasenfuss, 1994, Relation between myocardial function and expression of sarcoplasmic reticulum Ca2+-ATPase in failing and nonfailing human myocardium, Circ. Res., 75, 434, 10.1161/01.RES.75.3.434 · DOI · Paper page
- Dipla, 1999, The sarcoplasmic reticulum and the Na+/Ca2+ exchanger both contribute to the Ca2+ transient of failing human ventricular myocytes, Circ. Res., 84, 435, 10.1161/01.RES.84.4.435 · DOI · Paper page
- Movsesian, 1994, Ca2+-transporting ATPase, phospholamban, and calsequestrin levels in nonfailing and failing human myocardium, Circulation, 90, 653, 10.1161/01.CIR.90.2.653 · DOI · Paper page
- Hasenfuss, 1997, Calcium handling proteins in the failing human heart, Basic Res. Cardiol., 92, 87, 10.1007/BF00794072 · DOI · Paper page
- Houser, 2000, Abnormalities of calcium cycling in the hypertrophied and failing heart, J. Mol. Cell. Cardiol., 32, 1595, 10.1006/jmcc.2000.1206 · DOI · Paper page
- Dash, 2001, Gender influences on sarcoplasmic reticulum Ca2+-handling in failing human myocardium, J. Mol. Cell. Cardiol., 33, 1345, 10.1006/jmcc.2001.1394 · DOI · Paper page
- Miyauchi, 2006, Comprehensive analysis of expression and function of fifty-one sarco(endo)plasmic reticulum Ca2+-ATPase mutants associated with darier disease, J. Biol. Chem., 10.1074/jbc.M601966200 · DOI
- Tavadia, 2001, Platelet and cardiac function in Darier's disease, Clin. Exp. Dermatol., 26, 696, 10.1046/j.1365-2230.2001.00921.x · DOI
- Mayosi, 2006, Heterozygous disruption of SERCA2a is not associated with impairment of cardiac performance in humans: implications for SERCA2a as a therapeutic target in heart failure, Heart, 92, 105, 10.1136/hrt.2004.051037 · DOI
- Periasamy, 1999, Impaired cardiac performance in heterozygous mice with a null mutation in the sarco(endo)plasmic reticulum Ca2+-ATPase isoform 2 (SERCA2) gene, J. Biol. Chem., 274, 2556, 10.1074/jbc.274.4.2556 · DOI · Paper page
- Ji, 2000, Disruption of a single copy of the SERCA2 gene results in altered Ca2+ homeostasis and cardiomyocyte function, J. Biol. Chem., 275, 38073, 10.1074/jbc.M004804200 · DOI
- Schwinger, 1999, Reduced Ca2+-sensitivity of SERCA2a in failing human myocardium due to reduced serin-16 phospholamban phosphorylation, J. Mol. Cell. Cardiol., 31, 479, 10.1006/jmcc.1998.0897 · DOI · Paper page
- Gupta, 2003, Cardiac SR-coupled PP1 activity and expression are increased and inhibitor 1 protein expression is decreased in failing hearts, Am. J. Physiol.: Heart Circ. Physiol., 285, H2373
- El-Armouche, 2004, Decreased protein and phosphorylation level of the protein phosphatase inhibitor-1 in failing human hearts, Cardiovasc. Res., 61, 87, 10.1016/j.cardiores.2003.11.005 · DOI
- Pathak, 2005, Enhancement of cardiac function and suppression of heart failure progression by inhibition of protein phosphatase 1, Circ. Res., 96, 756, 10.1161/01.RES.0000161256.85833.fa · DOI · Paper page
- Molkentin, 1998, A calcineurin-dependent transcriptional pathway for cardiac hypertrophy, Cell, 93, 215, 10.1016/S0092-8674(00)81573-1 · DOI · Paper page
- Braz, 2004, PKC-alpha regulates cardiac contractility and propensity toward heart failure, Nat. Med., 10, 248, 10.1038/nm1000 · DOI · Paper page
- Marx, 2000, PKA phosphorylation dissociates FKBP12.6 from the calcium release channel (ryanodine receptor): defective regulation in failing hearts, Cell, 101, 365, 10.1016/S0092-8674(00)80847-8 · DOI · Paper page
- Lehnart, 2005, Phosphodiesterase 4D deficiency in the ryanodine–receptor complex promotes heart failure and arrhythmias, Cell, 123, 25, 10.1016/j.cell.2005.07.030 · DOI · Paper page
- Schmitt, 2003, Dilated cardiomyopathy and heart failure caused by a mutation in phospholamban, Science, 299, 1410, 10.1126/science.1081578 · DOI · Paper page
- Haghighi, 2006, A mutation in the human phospholamban gene, deleting arginine 14, results in lethal, hereditary cardiomyopathy, Proc. Natl. Acad. Sci. U. S. A., 103, 1388, 10.1073/pnas.0510519103 · DOI · Paper page
- Minamisawa, 2003, Mutation of the phospholamban promoter associated with hypertrophic cardiomyopathy, Biochem. Biophys. Res. Commun., 304, 1, 10.1016/S0006-291X(03)00526-6 · DOI
- del Monte, 2003, Targeting calcium cycling proteins in heart failure through gene transfer, J. Physiol., 546, 49, 10.1113/jphysiol.2002.026732 · DOI
- Hajjar, 1997, Physiological effects of adenoviral gene transfer of sarcoplasmic reticulum calcium ATPase in isolated rat myocytes, Circulation, 95, 423, 10.1161/01.CIR.95.2.423 · DOI · Paper page
- Davia, 2001, SERCA2a overexpression decreases the incidence of aftercontractions in adult rabbit ventricular myocytes, J. Mol. Cell. Cardiol., 33, 1005, 10.1006/jmcc.2001.1368 · DOI
- He, 1997, Overexpression of the rat sarcoplasmic reticulum Ca2+ ATPase gene in the heart of transgenic mice accelerates calcium transients and cardiac relaxation, J. Clin. Invest., 100, 380, 10.1172/JCI119544 · DOI · Paper page
- Baker, 1998, Targeted overexpression of the sarcoplasmic reticulum Ca2+-ATPase increases cardiac contractility in transgenic mouse hearts, Circ. Res., 83, 1205, 10.1161/01.RES.83.12.1205 · DOI · Paper page
- Ji, 1999, SERCA1a can functionally substitute for SERCA2a in the heart, Am. J. Physiol., 276, H89
- Muller, 2003, Transgenic rat hearts overexpressing SERCA2a show improved contractility under baseline conditions and pressure overload, Cardiovasc. Res., 59, 380, 10.1016/S0008-6363(03)00429-2 · DOI
- Maier, 2005, Increased SR Ca2+ cycling contributes to improved contractile performance in SERCA2a-overexpressing transgenic rats, Cardiovasc. Res., 67, 636, 10.1016/j.cardiores.2005.05.006 · DOI
- del Monte, 1999, Restoration of contractile function in isolated cardiomyocytes from failing human hearts by gene transfer of SERCA2a, Circulation, 100, 2308, 10.1161/01.CIR.100.23.2308 · DOI · Paper page
- Miyamoto, 2000, Adenoviral gene transfer of SERCA2a improves left-ventricular function in aortic-banded rats in transition to heart failure, Proc. Natl. Acad. Sci. U. S. A., 97, 793, 10.1073/pnas.97.2.793 · DOI · Paper page
- Vetter, 2002, Transgenic overexpression of the sarcoplasmic reticulum Ca2+ ATPase improves reticular Ca2+ handling in normal and diabetic rat hearts, FASEB J., 16, 1657, 10.1096/fj.01-1019fje · DOI
- Chen, 2004, Constitutive cardiac overexpression of sarcoplasmic/endoplasmic reticulum Ca2+-ATPase delays myocardial failure after myocardial infarction in rats at a cost of increased acute arrhythmias, Circulation, 109, 1898, 10.1161/01.CIR.0000124230.60028.42 · DOI
- Teucher, 2004, Excessive sarcoplasmic/endoplasmic reticulum Ca2+-ATPase expression causes increased sarcoplasmic reticulum Ca2+ uptake but decreases myocyte shortening, Circulation, 110, 3553, 10.1161/01.CIR.0000145161.48545.B3 · DOI
- He, 1999, Effects of mutant and antisense RNA of phospholamban on SR Ca2+-ATPase activity and cardiac myocyte contractility, Circulation, 100, 974, 10.1161/01.CIR.100.9.974 · DOI
- Ziolo, 2005, Adenoviral gene transfer of mutant phospholamban rescues contractile dysfunction in failing rabbit myocytes with relatively preserved SERCA function, Circ. Res., 96, 815, 10.1161/01.RES.0000163981.97262.3b · DOI
- Nakayama, 2003, Cardiac-specific overexpression of a high Ca2+ affinity mutant of SERCA2a attenuates in vivo pressure overload cardiac hypertrophy, FASEB J., 17, 61, 10.1096/fj.02-0474fje · doi:10.1096/fj.02-0474fje
- Dieterle, 2005, Gene transfer of a phospholamban-targeted antibody improves calcium handling and cardiac function in heart failure, Cardiovasc. Res., 67, 678, 10.1016/j.cardiores.2005.04.029 · DOI
- Eizema, 2000, Adenovirus-based phospholamban antisense expression as a novel approach to improve cardiac contractile dysfunction: comparison of a constitutive viral versus an endothelin-1-responsive cardiac promoter, Circulation, 101, 2193, 10.1161/01.CIR.101.18.2193 · DOI
- Meyer, 2004, A recombinant antibody increases cardiac contractility by mimicking phospholamban phosphorylation, FASEB J., 18, 1312, 10.1096/fj.03-1231fje · DOI
- del Monte, 2002, Targeting phospholamban by gene transfer in human heart failure, Circulation, 105, 904, 10.1161/hc0802.105564 · DOI · Paper page
- Minamisawa, 1999, Chronic phospholamban-sarcoplasmic reticulum calcium ATPase interaction is the critical calcium cycling defect in dilated cardiomyopathy, Cell, 99, 313, 10.1016/S0092-8674(00)81662-1 · DOI · Paper page
- Sato, 2001, Rescue of contractile parameters and myocyte hypertrophy in calsequestrin overexpressing myocardium by phospholamban ablation, J. Biol. Chem., 276, 9392, 10.1074/jbc.M006889200 · DOI
- Hoshijima, 2002, Chronic suppression of heart-failure progression by a pseudophosphorylated mutant of phospholamban via in vivo cardiac rAAV gene delivery, Nat. Med., 8, 864, 10.1038/nm739 · DOI · Paper page
- Iwanaga, 2004, Chronic phospholamban inhibition prevents progressive cardiac dysfunction and pathological remodeling after infarction in rats, J. Clin. Invest., 113, 727, 10.1172/JCI18716 · DOI · Paper page
- Delling, 2000, Re-evaluating sarcoplasmic reticulum function in heart failure, Nat. Med., 6, 942, 10.1038/79592 · doi:10.1038/79592
- Freeman, 2001, Alterations in cardiac adrenergic signaling and calcium cycling differentially affect the progression of cardiomyopathy, J. Clin. Invest., 107, 967, 10.1172/JCI12083 · DOI · Paper page
- Song, 2003, Rescue of cardiomyocyte dysfunction by phospholamban ablation does not prevent ventricular failure in genetic hypertrophy, J. Clin. Invest., 111, 859, 10.1172/JCI200316738 · DOI
- Antoons, 2003, Ca2+ uptake by the sarcoplasmic reticulum in ventricular myocytes of the SERCA2b/b mouse is impaired at higher Ca2+ loads only, Circ. Res., 92, 881, 10.1161/01.RES.0000069032.81501.98 · DOI
- Haghighi, 2003, Human phospholamban null results in lethal dilated cardiomyopathy revealing a critical difference between mouse and human, J. Clin. Invest., 111, 869, 10.1172/JCI17892 · DOI · Paper page
- Zhao, 2006, The presence of Lys27 instead of Asn27 in human phospholamban promotes sarcoplasmic reticulum Ca2+-ATPase superinhibition and cardiac remodeling, Circulation, 113, 995, 10.1161/CIRCULATIONAHA.105.583351 · DOI
- Arber, 1997, MLP-deficient mice exhibit a disruption of cardiac cytoarchitectural organization, dilated cardiomyopathy, and heart failure, Cell, 88, 393, 10.1016/S0092-8674(00)81878-4 · DOI · Paper page
- Antoons, 2006, Increased phospholamban phosphorylation limits the force-frequency response in the MLP−/− mouse with heart failure, J. Mol. Cell. Cardiol., 40, 350, 10.1016/j.yjmcc.2005.12.002 · DOI
- Hoit, 2006, Excitation–contraction coupling in the MLP knockout mouse, J. Mol. Cell. Cardiol., 40, 335, 10.1016/j.yjmcc.2006.01.004 · DOI
- Boateng, 1997, Inhibition of endogenous cardiac phosphatase activity and measurement of sarcoplasmic reticulum calcium uptake: a possible role of phospholamban phosphorylation in the hypertrophied myocardium, Biochem. Biophys. Res. Commun., 239, 701, 10.1006/bbrc.1997.7539 · doi:10.1006/bbrc.1997.7539
- Boknik, 2001, Enhanced protein phosphorylation in hypertensive hypertrophy, Cardiovasc. Res., 51, 717, 10.1016/S0008-6363(01)00346-7 · DOI
- Currie, 1999, Enhanced phosphorylation of phospholamban and downregulation of sarco/endoplasmic reticulum Ca2+ ATPase type 2 (SERCA 2) in cardiac sarcoplasmic reticulum from rabbits with heart failure, Cardiovasc. Res., 41, 135, 10.1016/S0008-6363(98)00241-7 · DOI
- Wu, 2004, An overview of stress echocardiography in the study of patients with dilated or hypertrophic cardiomyopathy, Echocardiography, 21, 467, 10.1111/j.0742-2822.2004.03083.x · doi:10.1111/j.0742-2822.2004.03083.x
- Wu, 2006, Local InsP3-dependent perinuclear Ca2+ signaling in cardiac myocyte excitation–transcription coupling, J. Clin. Invest., 116, 675, 10.1172/JCI27374 · DOI · Paper page
Cited by
Periasamy, M., Bhupathy, P., & Babu, G. J. (2007) · Cardiovascular Research · doi:10.1093/cvr/cvm056 · Cited by 259
Allosteric regulation of SERCA by phosphorylation-mediated conformational shift of phospholamban
Gustavsson, M., Verardi, R., Mullen, D. G., Mote, K. R., Traaseth, N. J., Gopinath, T., & Veglia, G. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1303006110 · Cited by 150
The Role of Sarcolipin and ATP in the Transport of Phosphate Ion into the Sarcoplasmic Reticulum
Becucci, L., Guidelli, R., Karim, C. B., Thomas, D. D., & Veglia, G. (2009) · Biophysical Journal · doi:10.1016/j.bpj.2009.08.035 · Cited by 21
Metadata
- Authors
- Vangheluwe, P., Sipido, K. R., Raeymaekers, L., & Wuytack, F.
- Venue
- Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
- Publisher
- Elsevier BV
- Published
- 2006-11
- Volume
- 1763
- Issue
- 11
- Pages
- 1216-1228
- ISSN
- 0167-4889
- Cited by
- 57
- References
- 9
- Language
- en
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 2451 d)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.